Cargando…
Apparent lack of prognostic value of MIB-1 index in anal carcinomas treated by radiotherapy.
This study was conducted to investigate the influence of Mib-1 index on outcome in 55 patients with T1-4 anal carcinomas treated radically by radiotherapy (RT) alone (24) or by concomitant chemo-radiotherapy (31). Median follow-up for surviving patients was 94 months (range 17-179 months). Tissue ma...
Autores principales: | Allal, A. S., Alonso-Pentzke, L., Remadi, S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150158/ https://www.ncbi.nlm.nih.gov/pubmed/9579842 |
Ejemplares similares
-
Cyclin D1, cyclin E, and p21 have no apparent prognostic value in anal carcinomas treated by radiotherapy with or without chemotherapy
por: Allal, A S, et al.
Publicado: (2004) -
Immunohistochemical study on the prognostic value of MIB-1 in gastric carcinoma.
por: Müller, W., et al.
Publicado: (1996) -
Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy
por: Allal, A S, et al.
Publicado: (1999) -
Insights into the prognostic value of DJ-1 and MIB-1 in astrocytic tumors
por: Abd El Atti, Rasha M, et al.
Publicado: (2013) -
MIB-1 labelling index is an independent prognostic marker in primary breast cancer.
por: Jansen, R. L., et al.
Publicado: (1998)